Mediprobe Research is a world class dermatology research and
clinical trials center.
We provide excellent and compassionate care to our patients
through modern state-of-the-art clinical trial facilities and
highly trained, dedicated staff. Together with a basic research
laboratory staffed with a team of skilled scientists, we are able
to conduct high quality research.
Together with a basic research laboratory staffed with a team of
highly skilled research scientists (6 staff: 5 Ph.D., 1 M.D.), we
are able to conduct quality research in the field of antifungal
therapeutics.
Mediprobe works with pharmaceutical companies to develop study
designs and write study protocols, case report forms and written
informed consent forms in-house. We conduct Phase II-IV clinical
trials to GCP standards and meet all applicable regulatory
requirements. We conduct pharmacokinetic trials and ship plasma
samples for bioanalytical assay. We also offer data entry from case
report forms, statistical analysis and the writing of final reports
and publications.
We have a track record of publishing 20-25 research papers each
year in peer-reviewed, indexed Medical Journals, in addition to
presentations at major North American and European research
meetings.
Mediprobe meets the demands of pharmaceutical companies to
conduct their trials safely and on time. Our expertise enables us
to start the projects efficiently and recruit patients quickly. Our
staff is familiar with ICH-GCP guidelines. We conduct international
clinical trials under Canadian and US INDs with clients from
Canada, the United States and abroad. We ensure that the clinical
trials are conducted according to the study protocol, the sponsor
guidelines and regulatory requirements.
In 2005, Mediprobe will undertake clinical trials in other
fields of medicine including hypertension, diabetes and
hypercholesterolemia.
Also in 2005, Mediprobe Research will expand its operations to
include a Phase I unit with a capacity of 54 beds. The new clinic
will allow conducting a wide variety of clinical trials in-house
where subjects can be institutionalized for days at a time. The new
studies include bioequivalence trials with oral formulations and
vasoconstrictive trials with topical corticosteroids.
- Acne
- Eczema/Atopic Dermatitis
- Actinic Keratosis
- Rosacea
- Onychomycosis
- Psoriasis
- Pustular Psoriasis
- Tinea Pedis
- Tinea Capitis
- Photoaging
- Dermatitis
- Skin Cancer
- Pharmacokinetic trials
- Melasma
Mediprobe has conducted over 75 clinical trials Phase II-IV in
dermatology in children and adults.
Our Advantages:
- Extended weekday hours (8 a.m. - 9 p.m.) as well as Saturday
appointments for patient convenience with free parking
- Central location, with easy access from Highways 401 and 402,
and London Airport
- On-site dermatology research laboratory
- Dedicated photographic studio
- Specialized light therapy on site
- Experience in conducting clinical trials requiring drug
administration via topical, intravenous, intramuscular, and
subcutaneous routes
- On site phlebotomy with extensive expertise in processing and
shipping samples
- Experience in electronic data capture and management of large
data bases
- In-house protocol development and data management
Our Facility:
- A custom designed 19,000 sq. ft. clinical trials facility with
a 2000 sq. ft. state-of-the-art laboratory dedicated to
dermatologic research
- Conference rooms for visiting monitors with phone/fax/internet
access
- Photographic studio with Canfield state-of-the-art camera
systems
- Secured medical file and chart storage facilities
- Dedicated, thermostat controlled, monitored and secured drug
storage facilities
- Monitored freezers (-40°C, -80°C) and fridges (0°
to 8°C)
- Back-up generator
- Documentation room
Aditya K. Gupta, M.D., Ph.D., M.A.(Cantab), DABD, FAAD,
FRCPC, Medical Investigator
Dr. Gupta is a board certified dermatologist who has extensive
experience in conducting clinical trials. He obtained a degree in
Engineering from King's College, University of Cambridge, U.K.
followed by his medical degree from the University of Southampton
Medical School, Southampton, U.K. He then did training in Internal
Medicine at the University of Toronto, Toronto, Canada and
subsequently a residency in dermatology and clinical trials
fellowship from the University of Michigan, Ann Arbor, MI, USA.
Dr. Gupta went on to perform research training at the National
Institutes of Health, Bethesda, MD, USA. This was followed by
further research in the Department of Dermatology, University of
Göteborg and Shalgrenska University Hospital, Göteborg, Sweden
where he obtained a Ph.D.
Dr. Gupta is an Associate Professor, Division of Dermatology,
Department of Medicine, Sunnybrook and Women's College Health
Sciences Center (Sunnybrook site) and the University of Toronto,
Toronto, Canada. Dr. Gupta has conducted approximately 75 Phase II,
III and IV clinical trials and has been a primary investigator at
Mediprobe Research Inc. for about 50 of those trials.
He has written over 400 articles and book chapters that have
appeared in journals published in the US, Canada, Europe and other
countries. Moreover, he is on the Editorial Board/ Advisory Board/
Section Editor of 20 journals:
- Clinics in Dermatology
- Cutis
- International Journal of Dermatology (Associate Editor)
- International Journal of Immunopathology and Pharmacology
(Associate Editor)
- Journal of the American Podiatric Medical Association
- Journal of Cutaneous Medicine and Surgery
- Journal of Dermatological Treatment
- Journal of Drugs in Dermatology (Senior Editor)
- Journal of the European Academy of Dermatology &
Venereology
- Medical Mycology (formerly Journal of Medical & Veterinary
Mycology)
- Mikologia Lekarska (Medical Mycology)
- Mycoses
- Pediatric Dermatology
- Podiatry Today
- Practical Dermatology
- Revista Iberoamericana de Micologia
- SKINmed: Dermatology for the clinician (Section Editor)
- Skin and Aging
- Skin Therapy Letter
Dr. Gupta serves on the Dermatology Expert Committee of the
United States Pharmacopoeia. He is the Treasurer and Board Member
of the Council of Nail Disorders. Dr. Gupta is also on the Board of
Directors of the Skin of Color Society.
Madhulika A. Gupta, M.D., FRCPC, President
Dr. Madhulika A. Gupta obtained her medical degree from the
University of Toronto, Toronto, Canada and then completed a
residency in Family Medicine followed by a residency in Psychiatry,
both at the University of Toronto. Dr. M. A. Gupta is a Certificant
of the College of Family Physicians of Canada and a Fellow of the
Royal College of Physicians of Canada. She is also a Diplomate of
the American Board of Psychiatry and Neurology and the American
Board of Sleep Medicine.
Dr. Gupta has been the principal investigator in various studies
in psychiatry and subinvestigator for several studies in
dermatology. She has over 70 publications in refereed journals, has
written several book chapters and presented at various national and
international conferences in both psychiatry and dermatology. She
regularly serves as a reviewer for medical journals in both
psychiatry and dermatology.
She currently has a private practice in psychiatry and is
involved in clinical research.
Jean-Maurice St-Onge, B.Sc. Pharm., M.Sc., Ph.D, Vice
President, Clinical Research
Dr. St-Onge holds a Doctorate degree in Pharmacology, a Master
degree in Pharmaceutical Sciences (pharmacokinetics) and a Bachelor
in Pharmacy from the Universite de Montreal. After practicing
pharmacy for six years, he moved to the industry where he gained
more than 21 years of experience in phase I-IV clinical trials in
Canada, the United States and in Europe with innovative, biotech,
generic and natural health products. He has held positions in
pharmaceutical and biotech companies and contract research
organizations in Canada.
He has broad experience in many therapeutics areas, including
oncology, gastrointestinal, anti-inflammatory, CNS, cardiovascular,
respiratory, dermatology and infectious diseases. He has had
strategic project management experience in bioequivalence studies
with generic products at Novopharm Limited for ten years. He has
also experience in the management of laboratories in research and
development.
His responsibilities include the sales and marketing of clinical
trials and the development and implementation of clinical research
projects. Dr. St-Onge is also responsible for the extension of the
operations of Mediprobe Research in bioequivalence studies in a
research center in 2005.
Muhammad M. Zaman, BA (Hons), MA, Ph.D., Vice President,
Analytical Research and Development
Dr. Muhammad Zaman holds a Bachelors Degree in Biochemistry,
Master's Degree in Molecular Biology, Doctoral degree in
Biochemistry as well as Postdoctoral Training in Infectious
Diseases from Harvard University. He also held the position of a
Senior Research Fellow at the Harvard School of Public Health prior
to joining Mediprobe Research, Inc. in October of 2003.
He has broad experience in many areas of molecular biology
including regulation of drug resistance genes in human pathogens,
genetic recombination mechanisms, and enzyme purification and
characterization.
His responsibilities include scientific and administrative
management of the analytical research and development arm of
Mediprobe Research, Inc.
Clinical Research Coordinators
The clinical team is comprised of 15 qualified clinical research
coordinators with experience in the management of clinical trials
in children and adults.
Our medical center has a patient pool of 750,000, covering all
of Southwestern Ontario, Canada. Our clinical trials are conducted
in adults and children.
For location information, please visit
www.mediproberesearch. com
To meet your clinical trial needs, we provide:
- Over 20 years experience in clinical trials
- Adherence to Good Clinical Practices (GCP), International
Conference on Harmonization
- Guidelines (ICH), and regulatory guidelines in conducting
clinical trials in Canada and the U.S.A.
- A track record of 15 or more ongoing studies each year over the
last 6 years
- A highly trained and experienced staff of 15 professionals
- State-of-the-art equipment
- Access to a central IRB with a short turnaround time
- Expertise in conducting Quality of Life Studies and
Questionnaire Design
- Data management and report writing
- Regulatory submissions
- Site management services
- Study protocols, consent forms and case report forms
- Regulatory compliance
- Quick turnaround contract negotiations
- Consultations for study designs
Dr. Aditya Gupta
Medical Investigator
Mediprobe Research
645 Windermere Road
London, Ontario N5X 2P1
Canada
Phone: 519-657-4222 ext. 277 Dr. Aditya Gupta
or ext. 228 Dr. Jean-Maurice St-Onge
Fax: 519-657-4233
EMail: agupta@mediproberesearch.com
Web Site: http://www.mediproberesearch.com
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the E-mail form below. A representative from
the research center will then follow up with you.
